Insmed Inc (INSM)

[wjlknew]

This is the most bizarre argument yet. You, and others, completely miss the whole point of "generics" ... which is to make a drug identical to an existing drug, but make it CHEAPER!!

The manufacturing of these drugs is being done now by the patent holders/licensees. The production facilities and expertise already exist and will not be destroyed by patent expiration. The whole idea of generics is to increase competition in order to bring down the price of these products. Dew's point is that Insmed apparently has no advantage over other manufacturing facilities which either already exist or may come on line before FDA rules are implemented ... assuming current legislation will be passed to allow the FDA to develop those rules.

The question which has repeatedly been asked ... and not adequately answered ... is why does Insmed hold any advantage over anyone else interested in entering a possible Biogeneric market? Does Insmed already have a manufacturing facility? Yes, but so do others. Does Insmed have the expertise to manufacture biologics? Yes, but so do others. Etc., etc., etc. The obvious answer is Insmed does not hold any advantage, and probably has some disadvantages because technologies are in existence, or are being developed, which may make Insmed's technology non-competitive. Can Insmed develop new technologies ... like transgenics? I suppose they can, but there is absolutely no indication they are, and they are at best late to the game.

Remember, the manufacturing facilities and expertise already exist to make these products. The purpose of generics is to make the products CHEAPER. Anyone is welcome to enter the fray ... and WILL enter the fray IF THERE IS ADEQUATE PROFIT INCENTIVE. To think Insmed is the only ... or even leading ... competitor is ludicrous.